• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的健康相关生活质量和 6 分钟步行距离。
Can Respir J. 2011 Sep-Oct;18(5):283-7. doi: 10.1155/2011/109635.
2
Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire.特发性肺纤维化特异性圣乔治呼吸问卷衍生版本的验证。
Respir Res. 2021 Oct 5;22(1):259. doi: 10.1186/s12931-021-01853-2.
3
Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者6分钟步行试验后的血氧饱和度恢复情况。
BMC Pulm Med. 2024 Jul 31;24(1):373. doi: 10.1186/s12890-024-03188-2.
4
Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.西地那非可改善特发性肺纤维化合并右心室功能障碍患者的运动能力。
Chest. 2013 Jun;143(6):1699-1708. doi: 10.1378/chest.12-1594.
5
Health-related quality of life does not predict mortality in idiopathic pulmonary fibrosis.与健康相关的生活质量并不能预测特发性肺纤维化的死亡率。
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):113-8.
6
Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis.《特发性肺纤维化圣乔治问卷》的西班牙语翻译及验证
Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):68-73. doi: 10.1016/j.arbres.2017.09.004. Epub 2017 Nov 2.
7
The St. George's Respiratory Questionnaire as a prognostic factor in IPF.圣乔治呼吸问卷作为特发性肺纤维化的一个预后因素
Respir Res. 2017 Jan 17;18(1):18. doi: 10.1186/s12931-017-0503-3.
8
Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients.两种用于测量特发性肺纤维化患者健康相关生活质量的问卷的比较。
Braz J Med Biol Res. 2007 Feb;40(2):179-87. doi: 10.1590/s0100-879x2007000200004.
9
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review.圣乔治呼吸问卷(SGRQ)在特发性肺纤维化患者中的心理测量学特性:一项文献综述。
Health Qual Life Outcomes. 2014 Aug 20;12:124. doi: 10.1186/s12955-014-0124-1.
10
Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.特发性肺纤维化患者的疾病严重程度和生活质量:IPF-PRO 注册研究的横断面分析。
Chest. 2020 May;157(5):1188-1198. doi: 10.1016/j.chest.2019.11.042. Epub 2020 Jan 15.

引用本文的文献

1
Health-related quality of life and health state utility value in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.特发性肺纤维化患者的健康相关生活质量和健康状态效用值:一项系统评价和荟萃分析。
Health Qual Life Outcomes. 2025 Jan 5;23(1):3. doi: 10.1186/s12955-024-02326-y.
2
Relationship of Exercise Capacity, Physical Function, and Frailty Measures With Clinical Outcomes and Healthcare Utilization in Lung Transplantation: A Scoping Review.肺移植中运动能力、身体功能及衰弱指标与临床结局和医疗资源利用的关系:一项综述。
Transplant Direct. 2022 Oct 7;8(11):e1385. doi: 10.1097/TXD.0000000000001385. eCollection 2022 Nov.
3
Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment.接受抗纤维化药物治疗的特发性肺纤维化患者进行肺康复的益处。
J Clin Med. 2022 Sep 11;11(18):5336. doi: 10.3390/jcm11185336.
4
Cardiorespiratory responses to muscle metaboreflex activation in fibrosing interstitial lung disease.纤维性间质性肺疾病中肌肉代谢反射激活的心肺反应。
Exp Physiol. 2022 May;107(5):527-540. doi: 10.1113/EP090252. Epub 2022 Mar 30.
5
A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis.一项系统性文献综述,旨在评估特发性肺纤维化患者的身体和心理症状负担以及姑息治疗情况。
Afr J Thorac Crit Care Med. 2019 Apr 12;25(1). doi: 10.7196/AJTCCM.2019.v25i1.231. eCollection 2019.
6
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.特发性肺纤维化患者的健康相关生活质量:系统评价和荟萃分析。
Eur Respir Rev. 2020 Nov 5;29(158). doi: 10.1183/16000617.0154-2020. Print 2020 Dec 31.
7
The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study.步行自行车对特发性肺纤维化患者生活质量和运动能力的影响:一项可行性研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):192-202. doi: 10.36141/svdld.v37i2.9433. Epub 2020 Jun 30.
8
Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis.有氧运动和呼吸练习可改善特发性肺纤维化患者的呼吸困难、运动能力和生活质量:系统评价与荟萃分析。
J Thorac Dis. 2020 Mar;12(3):1041-1055. doi: 10.21037/jtd.2019.12.27.
9
Reliability and Validity of the 6-Minute Walk Test in Hypophosphatasia.低磷酸酯酶症患者6分钟步行试验的可靠性和有效性
JBMR Plus. 2019 Mar 1;3(6):e10131. doi: 10.1002/jbm4.10131. eCollection 2019 Jun.
10
Validation of the COPD Assessment Test (CAT) in patients with idiopathic pulmonary fibrosis.慢性阻塞性肺疾病评估测试(CAT)在特发性肺纤维化患者中的验证
Eur Clin Respir J. 2018 Oct 16;5(1):1530028. doi: 10.1080/20018525.2018.1530028. eCollection 2018.

本文引用的文献

1
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.特发性肺纤维化患者的 6 分钟步行试验:纵向变化和最小临床重要差异。
Thorax. 2010 Feb;65(2):173-7. doi: 10.1136/thx.2009.113498. Epub 2009 Dec 8.
2
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.SF-36 和 SGRQ:在特发性肺纤维化中有效性和最小重要差异的初探。
Respir Med. 2010 Feb;104(2):296-304. doi: 10.1016/j.rmed.2009.09.006. Epub 2009 Oct 7.
3
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1).特发性肺纤维化患者应用波生坦治疗的生活质量和呼吸困难(BUILD-1)。
Eur Respir J. 2010 Jan;35(1):118-23. doi: 10.1183/09031936.00188108. Epub 2009 Aug 13.
4
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.用依那西普治疗特发性肺纤维化:一项探索性、安慰剂对照试验。
Am J Respir Crit Care Med. 2008 Nov 1;178(9):948-55. doi: 10.1164/rccm.200709-1446OC. Epub 2008 Jul 31.
5
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.BUILD-1:波生坦治疗特发性肺纤维化的随机安慰剂对照试验。
Am J Respir Crit Care Med. 2008 Jan 1;177(1):75-81. doi: 10.1164/rccm.200705-732OC. Epub 2007 Sep 27.
6
Health-related quality of life in patients with idiopathic pulmonary fibrosis--cross-sectional and longitudinal study.特发性肺纤维化患者的健康相关生活质量——横断面和纵向研究
Intern Med. 2007;46(18):1533-42. doi: 10.2169/internalmedicine.46.6218. Epub 2007 Sep 14.
7
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.晚期特发性肺纤维化患者肺动脉高压的患病率及预后
Chest. 2006 Mar;129(3):746-52. doi: 10.1378/chest.129.3.746.
8
High-dose acetylcysteine in idiopathic pulmonary fibrosis.高剂量乙酰半胱氨酸治疗特发性肺纤维化
N Engl J Med. 2005 Nov 24;353(21):2229-42. doi: 10.1056/NEJMoa042976.
9
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.患者对特发性肺纤维化如何影响其生活质量的看法。
Health Qual Life Outcomes. 2005 Oct 7;3:61. doi: 10.1186/1477-7525-3-61.
10
Standardisation of the single-breath determination of carbon monoxide uptake in the lung.肺一氧化碳摄取单次呼吸测定的标准化
Eur Respir J. 2005 Oct;26(4):720-35. doi: 10.1183/09031936.05.00034905.

特发性肺纤维化患者的健康相关生活质量和 6 分钟步行距离。

Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis.

机构信息

University of Alberta, Edmonton, Alberta.

出版信息

Can Respir J. 2011 Sep-Oct;18(5):283-7. doi: 10.1155/2011/109635.

DOI:10.1155/2011/109635
PMID:21969931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3267607/
Abstract

BACKGROUND

Few studies have investigated the relationship between physiological outcomes and quality of life in patients with idiopathic pulmonary fibrosis (IPF). Health-related quality of life (HRQL) data may provide a valuable patient-centred outcome for the evaluation of interventions. Determination of which physiological and functional variables are associated with HRQL may facilitate interpretation of disease progression and impacts of therapy.

OBJECTIVES

To determine whether an association between Medical Outcomes Short-Form 36 and St George's Respiratory Questionnaire scores and other markers of disease severity exist, and to identify which physiological and functional variables are independently associated with HRQL.

METHODS

In a cross-sectional study, 137 patients with IPF completed HRQL surveys and underwent clinical assessment. Multiple linear regression analysis was used to determine the relationship between age, forced vital capacity, diffusing capacity of carbon monoxide, 6 min walk distance (6MWD) and oxygen requirement, and HRQL scores.

RESULTS

6MWD was the only functional measure of disease severity significantly associated with all domain scores of the St George's Respiratory Questionnaire and the Medical Outcomes Short-Form 36 physical component summary score.

CONCLUSIONS

6MWD was associated with HRQL among patients with IPF. This highlights the importance of 6MWD not only as a prognostic indicator in IPF, but also a predictor of HRQL and a meaningful outcome for patients.

摘要

背景

很少有研究调查特发性肺纤维化 (IPF) 患者的生理结果与生活质量之间的关系。健康相关生活质量 (HRQL) 数据可能为评估干预措施提供有价值的以患者为中心的结果。确定哪些生理和功能变量与 HRQL 相关可能有助于解释疾病进展和治疗的影响。

目的

确定医疗结局短表 36 和圣乔治呼吸问卷评分与疾病严重程度的其他标志物之间是否存在关联,并确定哪些生理和功能变量与 HRQL 独立相关。

方法

在一项横断面研究中,137 名 IPF 患者完成了 HRQL 调查并接受了临床评估。多元线性回归分析用于确定年龄、用力肺活量、一氧化碳弥散量、6 分钟步行距离 (6MWD) 和氧气需求与 HRQL 评分之间的关系。

结果

6MWD 是唯一与圣乔治呼吸问卷和医疗结局短表 36 生理成分综合评分的所有领域评分显著相关的疾病严重程度的功能测量指标。

结论

6MWD 与 IPF 患者的 HRQL 相关。这突出了 6MWD 不仅作为 IPF 的预后指标的重要性,而且是 HRQL 的预测指标和患者有意义的结果。